PREVOZNIK MICHAEL E 4

4 · QUEST DIAGNOSTICS INC · Filed Mar 6, 2026

AI-generated summary of this filing

Updated Mar 6, 2026

Quest Diagnostics (DGX) PREVOZNIK MICHAEL E Receives Award, Sells Shares

What Happened

Michael E. PREVOZNIK (SVP & General Counsel) was issued a performance stock award of 7,232 shares on 2026-03-04 (value based on grant price $204.86 = $1,481,548).
To cover withholding taxes, 3,354 of those shares were surrendered on 2026-03-04 at $204.86 (value $687,100).
The remaining 3,878 shares were sold in an open-market transaction on 2026-03-05 at $206.21 for proceeds of $799,682.
This sequence (award → tax-withholding → sale) is routine for settling equity awards; the initial award was an acquisition, while part of the award was later disposed.

Key Details

Transaction dates/prices:
- 2026-03-04: Award of 7,232 shares at $204.86 (total $1,481,548).
- 2026-03-04: 3,354 shares withheld for taxes at $204.86 (value $687,100).
- 2026-03-05: 3,878 shares sold open market at $206.21 (proceeds $799,682).
Shares owned after transaction: not disclosed in the provided filing.
Notable footnotes:
- F1: Shares issued in settlement of a performance stock award (Rule 16b-3(d)).
- F2: 3,354-share disposition was to the issuer to cover tax withholding on the award.
- F3: The 3,878-share sale was effected under a Rule 10b5-1 sales plan.
- F4: (Plan-related note about periodic trustee purchases for 401(k)/deferred comp) — informational from plan administrator.
Filing: Form 4 was filed on 2026-03-06 covering transactions on 2026-03-04 and 2026-03-05 (no late‑filing indicator provided).

Context

This was a grant of performance shares, not an option exercise; part of the award was surrendered to cover taxes and the remainder sold under a pre-existing 10b5-1 plan — common procedures for equity compensation.
These actions are routine settlement and tax-covering transactions rather than a standalone bullish purchase signal.

Form 4

Period: 2026-03-04

SVP & General Counsel

Transactions

Holdings

Footnotes (4)

[F1]Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
[F2]Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.
[F3]This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
[F4]These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.

Signature

Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik|2026-03-06

1 file